GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers
Clinical trial NCT06076070 · UNKNOWN
Trial details
- NCT number
- NCT06076070
- Sponsor
- Regina Elena Cancer Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-25
- Primary completion
- 2024-05-25
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.